Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment
Cancer Biomarkers · 19.05.2022 · 34 (2) · 275-284
DOI: 10.3233/cbm-210345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, erschienen am 19.05.2022. Verfasst von Xun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Skills Center, Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Melanoma, Tripartite Motif Proteins, Tumor Suppressor Proteins, Uveal Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults with high metastasis rates. The O6-methylguanine DNA methyl transferase (MGMT) is involved in chemoresistance of Dacarbazine (DTIC) treatment. Our previous study found that the combination of oncolytic adenovirus H101 and DTIC in the treatment of UM cells shows a synergistic antitumor effect mainly though down-regulation of MGMT. MGMT knockdown by shRNAs increases the sensitivity of uveal melanoma cells to DTIC treatment. The protein hemostasis of MGMT is important for the antitumor effect of DTIC. Tripartite motif-containing protein 72 (TRIM72) belongs to the tripartite motif (TRIM) proteins family and was identified as a novel E3 ligase for MGMT, which interacts with and mediates the ubiquitination of MGMT. TRIM72 knockdown increases the protein levels of MGMT, while reduces the ubiquitination of MGMT. Further study indicated that MGMT is highly expressed in UM cells, and the protein levels of MGMT and TRIM72 shows a negative correlation. UM cells that ectopically expressing TRIM72 shows increased sensitivity to DTIC treatment, which is consistent with the antitumor affect exhibited by H101. These results suggest that TRIM72 is a promising therapeutic target for UM treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Skills Center, Kunming Medical University, Kunming, Yunnan, China.
- Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Zitieren
APA
Li, X., Yang, C., Luo, N., Yang, Y., Guo, Y., Chen, P., & Cun, B. (2022). Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment. Cancer Biomarkers, 34(2), 275-284. https://doi.org/10.3233/cbm-210345
Vancouver
Li X, Yang C, Luo N, Yang Y, Guo Y, Chen P, et al. Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment. Cancer Biomarkers. 2022;34(2):275-284. doi:10.3233/cbm-210345
BibTeX
@article{Li2022,
author = {Li, Xun and Yang, Cong and Luo, Ning and Yang, Yunzhi and Guo, Yan and Chen, Ping and Cun, Biyun},
title = {Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment},
journal = {Cancer Biomarkers},
year = {2022},
volume = {34},
number = {2},
pages = {275--284},
doi = {10.3233/cbm-210345}
}
EUVIMED